Logo

Revolutionizing the treatment of fibrotic disease.

Latest News

Blade Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference

August 1, 2019

Blade Therapeutics Announces Publication of Preclinical Data Supporting Calpain 9 as a Promising Therapeutic Target for Fibrotic Disease

July 31, 2019

Blade Therapeutics Announces Initiation of Phase 1 Study of Lead Calpain Inhibitor BLD-2660 for Fibrosis

July 17, 2018
more news »

Innovation

Learn More

Our Team

Learn More

Careers

Learn More

Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Investors
    • In Memoriam
  • Innovation
  • R&D
  • News & Events
    • News
      • August 1, 2019
      • July 31, 2019
      • July 17, 2018
      • March 6, 2018
      • February 27, 2018
      • October 18, 2017
      • August 21, 2017
      • June 20, 2017
      • June 16, 2016
    • Events
  • Partners
  • Careers
  • Contact
  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Investors
    • In Memoriam
  • Innovation
  • R&D
  • News & Events
    • News
      • August 1, 2019
      • July 31, 2019
      • July 17, 2018
      • March 6, 2018
      • February 27, 2018
      • October 18, 2017
      • August 21, 2017
      • June 20, 2017
      • June 16, 2016
    • Events
  • Partners
  • Careers
  • Contact

  • Blade Therapeutics, Inc.
    442 Littlefield Avenue
    South San Francisco, CA 94080
    Phone: (650) 278-4291

© 2019 Blade TherapeuticsAll rights reservedWebsite Design: Hane Chow, Inc.